Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Agile Therapeutics Inc
(NQ:
AGRX
)
0.6022
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Mar 25, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Agile Therapeutics Inc
< Previous
1
2
Next >
Agile Therapeutics Announces Pricing of $7.5 Million Public Offering
May 22, 2023
From
Agile Therapeutics, Inc.
Via
GlobeNewswire
Agile Therapeutics Reports First Quarter 2023 Financial Results And Provides Corporate Update
May 11, 2023
From
Agile Therapeutics, Inc.
Via
GlobeNewswire
Agile Therapeutics to Report First Quarter 2023 Financial Results and Provide Business Update on Thursday, May 11, 2023
May 08, 2023
Live Conference Call and Webcast at 4:30 p.m. ET
From
Agile Therapeutics, Inc.
Via
GlobeNewswire
Agile Therapeutics: This BioPharma Firm Is Nimbly Solving Unmet Needs For Women
January 20, 2023
By Johnny Rice, Benzinga
Via
TheNewswire.com
NASDAQ: AGRX Agile Therapeutics Anticipates Increased Growth In Q3 of 2022
October 21, 2022
Matt Riley - Head of Investor Relations & Corporate Communications
Via
TheNewswire.com
Proprietary Transdermal Advancements for Easier, Non-Daily Contraception Options in Women: Agile Therapeutics (NASDAQ: AGRX)
July 19, 2021
Via
Get News
Agile Therapeutics Announces Preliminary Expectations for First Quarter 2023
April 28, 2023
From
Agile Therapeutics, Inc.
Via
GlobeNewswire
Agile Therapeutics Regains Compliance With Nasdaq Minimum Bid Price Requirement
April 26, 2023
From
Agile Therapeutics, Inc.
Via
GlobeNewswire
Agile Therapeutics Announces 1-For-50 Reverse Stock Split
April 10, 2023
From
Agile Therapeutics, Inc.
Via
GlobeNewswire
Agile Therapeutics Reports Fourth Quarter & Full Year 2022 Financial Results and Provides Corporate Update
March 22, 2023
From
Agile Therapeutics, Inc.
Via
GlobeNewswire
Agile Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results and Provide Business Update on Wednesday, March 22, 2023
March 21, 2023
Live Conference Call and Webcast at 4:30 p.m. ET
From
Agile Therapeutics, Inc.
Via
GlobeNewswire
Agile Therapeutics Granted 180-Day Extension by Nasdaq to Meet the Minimum Bid Price Requirement
February 27, 2023
From
Agile Therapeutics, Inc.
Via
GlobeNewswire
Agile Therapeutics Provides Clinical Update on Twirla and Status of Pipeline Evaluation
February 01, 2023
From
Agile Therapeutics, Inc.
Via
GlobeNewswire
Agile Therapeutics Announces Distribution of Series C Preferred Stock to its Holders of Common Stock
January 26, 2023
From
Agile Therapeutics, Inc.
Via
GlobeNewswire
Agile Therapeutics Provides Updates on 2022 Twirla Performance and 2023 Commercial Plan
January 09, 2023
From
Agile Therapeutics, Inc.
Via
GlobeNewswire
This Biotech Company is Pursuing Positive Cash Flow In 2023
December 21, 2022
Biotech company Agile Therapeutics Inc. (NASDAQ: AGRX) began selling its contraceptive patch in 2021, and the company is pursuing positive cash flow by the end of 2023.
Via
TheNewswire.com
Agile Therapeutics To Present At The Upcoming RHK Capital Disruptive Growth Conference
December 01, 2022
From
Agile Therapeutics, Inc.
Via
GlobeNewswire
Women’s Healthcare Company Agile Therapeutics Says It Believes It Has An Effective Business Plan In Place For Growth And Generating Positive Cash Flow
November 15, 2022
Agile Therapeutics Inc. (NASDAQ: AGRX) is on a journey to fulfill the unmet health needs of women with products designed to provide them with contraceptive options.
Via
TheNewswire.com
Agile Therapeutics Reports Third Quarter 2022 Financial Results and Provides Corporate Update
November 07, 2022
From
Agile Therapeutics, Inc.
Via
GlobeNewswire
Agile Therapeutics to Report Third Quarter 2022 Financial Results and Provide Business Update on Monday, November 7, 2022
October 26, 2022
Live Conference Call and Webcast at 4:30 p.m. ET
From
Agile Therapeutics, Inc.
Via
GlobeNewswire
Can This Company’s Birth Control Patch Disrupt The Contraceptive Market?
October 26, 2022
From Evofem Biosciences Inc.’s (OTCMKTS: EVFM) Phexxi vaginal gel contraceptive to Dare Bioscience Inc.’s (NASDAQ: DARE) Ovaprene, an investigational hormone-free monthly intravaginal contraceptive,...
Via
TheNewswire.com
Agile Therapeutics Announces Reorganization of Leadership Team
October 07, 2022
From
Agile Therapeutics, Inc.
Via
GlobeNewswire
Agile Therapeutics to Report Second Quarter 2022 Financial Results and Provide Business Update on Thursday, August 11, 2022
July 28, 2022
Live Conference Call and Webcast at 4:30 p.m. ET
From
Agile Therapeutics, Inc.
Via
GlobeNewswire
Women’s Healthcare Company dedicated to fulfilling the unmet health needs of today’s Modern Women: Agile Therapeutics (NASDAQ: AGRX)
July 06, 2021
Via
Get News
50+ Companies to Present at the Access to Giving Virtual Investor Conference on July 13th - 15th, 2021
July 08, 2021
RALEIGH, NC / ACCESSWIRE / July 8, 2021 / Access to Giving - an investor conference themed around investor education and advocacy begins next week, July 13th - 15th, 2021. More than 50 companies are...
From
Access to Giving
Via
AccessWire
50+ Companies to Present at the Access to Giving Virtual Investor Conference on July 13th - 15th, 2021
June 23, 2021
RALEIGH, NC / ACCESSWIRE / June 23, 2021 / Access to Giving - an investor conference themed around investor education and advocacy is set for July 13-15, 2021. There will be 50+ companies conducting...
From
Access to Giving
Via
AccessWire
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.